SURG vs CRM: Which Stock is Better?
Side-by-side comparison of Surgepays Inc and Salesforce Inc in 2026
SURG
Surgepays Inc
$0.66
CRM
Salesforce Inc
$182.14
Key Metrics Comparison
| Metric | SURG | CRM | Winner |
|---|---|---|---|
| Market Cap | $16.25M | $169.80B | CRM |
| P/E Ratio | N/A | 23.26 | CRM |
| EPS (TTM) | $N/A | $7.79 | CRM |
| Revenue Growth | 2.9% | 0.1% | SURG |
| Gross Margin | -38.6% | 77.7% | CRM |
Analyze SURG
Full quant analysis
Analyze CRM
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is SURG or CRM a better investment?
Comparing SURG and CRM: Surgepays Inc has a market cap of $16.25M while Salesforce Inc has $169.80B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between SURG and CRM?
SURG (Surgepays Inc) and CRM (Salesforce Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: SURG or CRM?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: SURG or CRM?
SURG has higher revenue growth at 2.9% vs 0.1% for CRM.
Which company is more profitable: SURG or CRM?
Salesforce Inc (CRM) has higher gross margins at 77.7% compared to -38.6% for SURG.
Which is the larger company: SURG or CRM?
Salesforce Inc (CRM) is larger with a market cap of $169.80B compared to $16.25M for SURG.
Should I buy SURG or CRM in 2026?
Both SURG and CRM have investment merit. SURG trades at $0.66 while CRM trades at $182.14. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between SURG and CRM stock?
Key differences: Market Cap ($16.25M vs $169.80B), P/E Ratio (N/A vs 23.3x), Revenue Growth (2.9% vs 0.1%), Gross Margin (-38.6% vs 77.7%).